Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-05-17 @ 12:46 AM
Study NCT ID:
NCT00882869
Status:
COMPLETED
Last Update Posted:
2011-07-13
First Post:
2009-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
Sponsor:
Aegera Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AEG35156-205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Jacques Jolivet, MD, Senior VP Clinical
Old Organization:
Aegera Therapeutics Inc
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |